VALIDATING CONDITIONALLY REPROGRAMMED CELLS TO ADVANCE PERSONALIZED MEDICINE FOR PROSTATE CANCER

$264,540FY2013Department of the ArmyDOD

George Mason University, Fairfax VA

Investigators